#ASH17: Blue­bird touts ear­ly signs that its new-and-im­proved sick­le cell gene ther­a­py is work­ing

Blue­bird bio $BLUE says they’ve been able to gath­er ev­i­dence to help prove that their new-and-im­proved ap­proach to mak­ing a gene ther­a­py for sick­le cell …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.